ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
122.799,09
-1,60%
S&P 500
5.954,50
1,59%
US Dollar vs BRL
5,886
0,00%
Bitcoin
84.675,34
0,36%
Brent Oil
73,045
0,00%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Skye Bioscience Inc (SKYE)

  7. Skye Bioscience Inc (SKYE) Notícias

SKYE

Skye Bioscience (SKYE)

Skye Bioscience Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SKYE
DataHoraFonteTítuloCódigoCompanhia
28/02/202520:54Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:SKYESkye Bioscience Inc
26/02/202521:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SKYESkye Bioscience Inc
26/02/202519:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SKYESkye Bioscience Inc
19/12/202420:09Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:SKYESkye Bioscience Inc
15/11/202419:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SKYESkye Bioscience Inc
14/11/202411:21Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SKYESkye Bioscience Inc
07/11/202418:18Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SKYESkye Bioscience Inc
07/11/202418:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SKYESkye Bioscience Inc
23/09/202418:25Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SKYESkye Bioscience Inc
13/09/202418:18Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SKYESkye Bioscience Inc
04/09/202418:25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SKYESkye Bioscience Inc
24/07/202408:30GlobeNewswire Inc.Beacon Biosignals Announces Strategic Collaboration with Skye Bioscience to Integrate Sleep Quality and Sleep Apnea Endpoints in CBEYOND™ Phase 2 Trial of Nimacimab for ObesityNASDAQ:SKYESkye Bioscience Inc
20/05/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SKYESkye Bioscience Inc
17/05/202417:27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SKYESkye Bioscience Inc
10/05/202417:19Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SKYESkye Bioscience Inc
17/06/201010:00MarketwiredMarshall Edwards Announces Additional Management Changes With Appointment of New Chief Financial OfficerNASDAQ:SKYESkye Bioscience Inc
25/03/201004:16MarketwiredSkyePharma PLC announces Final ResultsNASDAQ:SKYESkye Bioscience Inc
21/01/201013:59MarketwiredSkyepharma PLC announces - Regulatory UpdateNASDAQ:SKYESkye Bioscience Inc
18/11/200905:00MarketwiredSkyepharma PLC - Board ChangeNASDAQ:SKYESkye Bioscience Inc
12/11/200905:00MarketwiredSkyepharma PLC - Interim Management StatementNASDAQ:SKYESkye Bioscience Inc
02/11/200908:23MarketwiredFlutiform EU Clinical Trial Successfully CompletedNASDAQ:SKYESkye Bioscience Inc
01/09/200903:00MarketwiredSKYEPHARMA PLC - Research UpdateNASDAQ:SKYESkye Bioscience Inc
22/06/200911:42MarketwiredSkyepharma PLC announces Conversion of BondsNASDAQ:SKYESkye Bioscience Inc
09/06/200911:14MarketwiredSkyepharma PLC Announces Research UpdateNASDAQ:SKYESkye Bioscience Inc
22/05/200903:09MarketwiredSkyePharma PLC: Flutiform NDA Accepted for ReviewNASDAQ:SKYESkye Bioscience Inc
15/05/200903:03MarketwiredSkyepharma PLC announces Board AppointmentNASDAQ:SKYESkye Bioscience Inc
15/05/200903:00MarketwiredSkyepharma Announces Interim Management StatementNASDAQ:SKYESkye Bioscience Inc
31/03/200903:17MarketwiredSkyepharma - Re AgreementNASDAQ:SKYESkye Bioscience Inc
26/03/200904:05MarketwiredSkyepharma PLC Announces Final ResultsNASDAQ:SKYESkye Bioscience Inc
23/03/200904:00MarketwiredSkyepharma PLC Announces Regulatory ApplicationNASDAQ:SKYESkye Bioscience Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SKYE

Seu Histórico Recente

BIT
NSCIT1265940
Societe Generale
BIT
UC7PXF
Unicredit Bank
BIT
I10452
IT0005615965 20250303 7.2
BIT
P1OJ21
BNP Paribas Issuance
BIT
W2LKL9
UBS
BIT
UB5FY0
Unicredit Bank
BIT
UC92UM
Unicredit Bank
BIT
UB7HQF
Unicredit Bank
AQSE
WRN.GB
Worthington
TSX
KL
Kirkland Lake Gold
BIT
UC7LVM
Unicredit Bank
BIT
P1KMR9
BNP Paribas Issuance
BIT
P1FL51
BNP Paribas Issuance
BIT
UC74RD
Unicredit Bank
BIT
F34710
Vontobel Financial Produ...
BIT
BTP10
Etf
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios